Alfonso Bellacosa

5PUBLICATIONS
15CO-AUTHORS
Molecular targetsHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 29, 2024
AKT kinases as therapeutic targets.

Dalal Hassan, Craig W Menges, Joseph R Testa

|Oct 22, 2024
AKT and the Hallmarks of Cancer.

Eleonora Sementino, Dalal Hassan, Alfonso Bellacosa

|Jan 09, 2023
Active DNA demethylation-The epigenetic gatekeeper of development, immunity, and cancer.

Rahul Prasad, Timothy J Yen, Alfonso Bellacosa

|Aug 30, 2022
The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells.

Alison M Kurimchak, Carlos Herrera-Montávez, Sara Montserrat-Sangrà

|Jun 23, 2021
Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells.

Atsushi Onodera, Edahí González-Avalos, Chan-Wang Jerry Lio

Pageof 1

Frequent Collaborators

1 joint publications

Atsushi Onodera

1 joint publications

Edahí González-Avalos

1 joint publications

Chan-Wang Jerry Lio

1 joint publications

Romain O Georges